Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.91M Buy
97,086
+81,689
+531% +$2.59M ﹤0.01% 1848
2025
Q4
$450K Buy
+15,397
New +$408K ﹤0.01% 2343
2020
Q4
Sell
-1,648,805
Closed -$20.6M 2567
2020
Q3
$20.6M Buy
+1,648,805
New +$20.3M 0.01% 751
2019
Q4
Sell
-450,760
Closed -$6.77M 2698
2019
Q3
$6.77M Buy
450,760
+142,820
+46% +$2.14M ﹤0.01% 1091
2019
Q2
$4.61M Buy
307,940
+271,900
+754% +$3.89M ﹤0.01% 1231
2019
Q1
$518K Sell
36,040
-965
-3% -$14.2K ﹤0.01% 2095
2018
Q4
$530K Sell
37,005
-145
-0.4% -$2.27K ﹤0.01% 1969
2018
Q3
$602K Sell
37,150
-345
-0.9% -$5.56K ﹤0.01% 2007
2018
Q2
$592K Buy
37,495
+690
+2% +$11.9K ﹤0.01% 2025
2018
Q1
$661K Sell
36,805
-85
-0.2% -$1.54K ﹤0.01% 1921
2017
Q4
$626K Sell
36,890
-1,825
-5% -$30.9K ﹤0.01% 1900
2017
Q3
$627K Sell
38,715
-8,190
-17% -$132K ﹤0.01% 1870
2017
Q2
$731K Sell
46,905
-110
-0.2% -$1.72K ﹤0.01% 1776
2017
Q1
$699K Sell
47,015
-4,445
-9% -$68.9K ﹤0.01% 1762
2016
Q4
$801K Sell
51,460
-3,315
-6% -$50.9K ﹤0.01% 1641
2016
Q3
$812K Sell
54,775
-4,685
-8% -$66.1K ﹤0.01% 1767
2016
Q2
$760K Sell
59,460
-2,245
-4% -$31.3K ﹤0.01% 1765
2016
Q1
$881K Sell
61,705
-503,605
-89% -$6.86M ﹤0.01% 1686
2015
Q4
$7.94M Buy
565,310
+10,695
+2% +$156K 0.01% 920
2015
Q3
$7.2M Buy
554,615
+7,395
+1% +$103K 0.01% 954
2015
Q2
$8.16M Buy
547,220
+14,690
+3% +$227K 0.01% 944
2015
Q1
$7.49M Buy
532,530
+6,745
+1% +$88.2K 0.01% 952
2014
Q4
$6.58M Sell
525,785
-42,405
-7% -$555K 0.01% 979
2014
Q3
$7.84M Buy
568,190
+11,480
+2% +$176K 0.01% 921
2014
Q2
$9.25M Buy
556,710
+79,700
+17% +$1.21M 0.01% 873
2014
Q1
$6.72M Sell
477,010
-45,520
-9% -$696K 0.01% 962
2013
Q4
$9.31M Sell
522,530
-10,610
-2% -$182K 0.01% 839
2013
Q3
$8.72M Buy
533,140
+1,345
+0.3% +$20K 0.01% 841
2013
Q2
$7.27M Buy
+531,795
New +$7.51M 0.01% 861

Other funds holding IX

UBS AM's IX Position: Q1 2026 in Review

UBS AM increased its ORIX (IX) stake by 531% in Q1 2026, buying an estimated $2.59M and bringing the position to 97,086 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1848.

UBS AM first reported a position in IX in Q2 2013 and has held it in 29 quarters since. The position peaked at $20.6M in Q3 2020. 280 funds tracked by Wall St. Rank hold IX as of Q1 2026.

  • UBS AM held 97,086 shares of ORIX worth $2.91M as of Q1 2026.
  • UBS AM bought 81,689 ORIX shares in Q1 2026, an estimated $2.59M.
  • ORIX made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1848 holding.
  • UBS AM first reported a position in ORIX in Q2 2013 and has held it in 29 quarters since.
  • UBS AM's ORIX position peaked at $20.6M in Q3 2020.
  • 280 funds tracked by Wall St. Rank held ORIX as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.